Alimta

...Investigational Targeted Therapy May Offer Progress for Non-Hodgkin's Lymphoma Patients: Financial News - Yahoo!

Finance Yahoo!

My Yahoo!

Mail Welcome, Guest [Sign Out, My Account] Finance Home - Help Welcome [Sign In] To track stocks & more, Register Financial NewsEnter symbol(s) BasicPerformanceReal-time MktDetailedChartResearchOptionsOrder Book Symbol Lookup Press ReleaseSource: Eli Lilly and Company Investigational Targeted Therapy May Offer Progress for Non-Hodgkin's Lymphoma PatientsSaturday December 10, 9:15 am ET INDIANAPOLIS, Dec.

10 /PRNewswire-FirstCall/ - Data presented today offer evidence that an investigational targeted therapy may be useful in treating patients with the most common form of non-Hodgkin's lymphoma (NHL).

The five-year survival rate of U.S.

patients with NHL is only 59 percent with standard therapies, according to the Lymphoma Research Foundation.

Diffuse large B-cell lymphoma (DLBCL) is the most frequent form of NHL (1).

Conventional therapies improve outcomes for some patients, but new treatment options are always needed.Phase II data presented today at the American Society of Hematology (ASH) 47th Annual Meeting and Exposition in Atlanta, Georgia, showed enzastaurin HCl, an investigational compound from Lilly Oncology, slowed the progression of DLBCL in several patients pretreated with chemotherapy."The use of enzastaurin in relapsed diffuse large B-cell lymphoma is important for two reasons," said Margaret A.

Shipp, M.D.

director of...

... Analysts back Lilly`s rosy forecast M&C News Index U.S.

U.K.

Americas Europe Middle East Asia-Pacific South Asia Africa Business Education Health News Roundups Features Specials Intel/Terror Iraq with Pamela Hess Daily Almanac Watercooler Stories Lifestyle Consumer Health Horoscope Life Travel Search Released This Week Movies - USA Movies - UK DVD - USA DVD - UK Books Specials Oscars 2006: 78th Academy Awards Topics Comics Space Entertainment Arts Books DVD Movies Music People Soundtracks Sport TV News U.S.

U.K.

Americas Europe Middle East Asia-Pacific South Asia Africa Business Education Health Science Tech Lifestyle Consumer Health Horoscope Life Travel Network Sites War of the Worlds Media Movie Stills Movie Trailers Movie Posters Movie Premieres DVD Stills DVD Clips Theatre Stills TV Stills TV Clips Soundtrack Radio Concert Photos Best Sellers Books DVD's Soundtracks Corporate About Us Advertise Contact Staff Vacancies Advertisement Business News Analysts back Lilly`s rosy forecast By Steve Mitchell Dec 10, 2005, 3:03 GMT printer friendly email this article WASHINGTON, DC, United States (UPI) - Eli Lilly said Friday it was in a unique position to deliver sustained growth, and analysts seem to agree with the company`s rosy assessment.

'I think they have one of the better business models out there in large-cap pharmaceuticals,' Scott Henry, an analyst with Oppenheimer and Co., told United Press International.

Henry said they have a unique c...

... United Press International - Health Business - Analysts back Lilly's rosy forecast United Press InternationalNews.

Analysis.

Insight.

Advertise Search 12/9/2005 4:30:00 PM -0500 Newstrack: Decades after the drug Thalidomide was prescribed in Britain leaving children with missing limbs, those affected got an apology and more funds.

New Jersey Gov.-elect Jon Corzine announced Friday that U.S.

Rep.

Robert Menendez, a fellow Democrat, will take his U.S.

Senate seat.

A 31-year-old New Orleans mother and her 3-year-old son saved from rampaging floodwaters in Hurricane Katrina were killed in a Milwaukee apartment fire.

Richard Williams has admitted lying to a friend who was trying to promote a "battle of the sexes" tennis match featuring his daughters, Venus and Serena.

Federal agents are into their second month searching for three men who stole $7.4 million cash at gunpoint from a Miami airport warehouse.

An attorney representing five gay couples says he will appeal a New York appellate court ruling striking down same-sex marriage.

Israel, concerned about global terrorism, no longer will send its warships through the Suez Canal, re...